The 9.4% return this week takes Aclaris Therapeutics’ (NASDAQ:ACRS) shareholders one-year gains to 510%

August 25, 2021
10:16 am

The 9.4% return this week takes Aclaris Therapeutics’ (NASDAQ:ACRS) shareholders one-year gains to 510%

Some Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shareholders are probably rather concerned to see the share price fall 30% over the last three months. But that isn’t a problem when you consider how the share price has soared over the last year. In that time,…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

ChinaAMC Unveils Strategy for H2 as AI Shifts from Conviction to Earnings

July 22, 2026

XRP Rally Slows On S&P Dow Jones Crypto Index Exclusion

July 22, 2026

Solana, Cardano & Crypto – European Wrap 22 July

July 22, 2026

Bitcoin Tests $68,000 Resistance as Crypto Bill Odds Rise

July 22, 2026

Why are Bitcoin, Ethereum and XRP poised to extend recovery?

July 22, 2026

XRP Holders Cheer as Bessent Says Major Crypto Bill ‘On the 1-Yard Line’

July 22, 2026

Traders give crypto’s landmark US market structure bill a coin-flip chance

July 22, 2026

Replenish Nutrients Announces Strategic Relationship with SRC Agrominerals, including $15 Million Strategic Investment, Beiseker Facility Expansion and Supply Agreement

July 22, 2026